[EN] TRICYCLIC COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS<br/>[FR] COMPOSÉS TRICYLIQUES UTILISÉS COMME LIGANDS DU RÉCEPTEUR NICOTINIQUE ALPHA-7 DE L'ACÉTYLCHOLINE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2015191403A1
公开(公告)日:2015-12-17
The disclosure provides compounds of formula I including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic 7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders. [INSERT CHEMICAL STRUCTURE HERE] I
本公开提供了公式I的化合物,包括它们的盐,以及使用这些化合物的组合物和方法。这些化合物是烟酸7受体的配体,可能用于治疗各种中枢神经系统疾病,尤其是情感和神经退行性疾病。 [在此插入化学结构] I
INHIBITORS OF CAMKK2 AND USES OF SAME
申请人:New York University
公开号:US20200369656A1
公开(公告)日:2020-11-26
The present disclosure provides compounds suitable for inhibiting CaMKK2. Also provided are compositions and methods of treating diseases associated with CaMKK2.
本公开提供适用于抑制CaMKK2的化合物。还提供了与CaMKK2相关疾病的治疗方法和组合物。
Halogeno-substituted 2- and 3-methylbenzo[b]thiophenes: Use of1H NMR spectral analysis and1H{1H} nuclear Overhauser effect for locating the halogen substituent
作者:Ma. Rosa Cuberes、Marcial Moreno-Mañas、Francisco Sánchez-Ferrandom
DOI:10.1002/mrc.1260231006
日期:1985.10
halogenomethyl)‐benzo [b]thiophenes, including 17 new compounds, were prepared. The constitution of 14 of these was confirmed by full analysis (LAOCOON) of their 80 MHz1HNMR spectra and by 1H1H} NOE measurements. In this way a by‐product from the preparation of 4‐ and 6‐bromo‐3‐bromomethylbenzo[b]thiophenes was shown conclusively to be 5‐bromo‐3‐bromomethylbenzo[b]thiophene. The 3‐substituted benzo[b]thiophenes showed
[EN] TRICYCLIC COMPOUNDS AS ALPHA- 7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS<br/>[FR] COMPOSÉS TRICYCLIQUES EN TANT QUE LIGANDS DU RÉCEPTEUR NICOTINIQUE DE L'ACÉTYLCHOLINE ALPHA-7
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2015191401A1
公开(公告)日:2015-12-17
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic α7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.
The present disclosure provides compounds suitable for inhibiting CaMKK2. Also provided are compositions and methods of treating diseases associated with CaMKK2.